Latest Marketable Securities News

AVITA Medical reported a mixed fourth quarter with revenue pressures easing and full-year growth, underpinned by a new $60 million credit facility and advancing clinical trials.

AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.

Bravura Solutions has delivered a robust first half of FY26, posting nearly 10% revenue growth and a significant jump in profitability, while rewarding shareholders with a special dividend. The company also upgraded its full-year guidance, signalling confidence in its growth trajectory.

Global Masters Fund Limited reports steady convertible note activity and a robust loan-to-value ratio of 9.36% for the December 2025 quarter, underscoring its solid financial footing.

Flagship Investments Limited has confirmed stable financial metrics for its convertible notes in the December 2025 quarter, maintaining a conservative loan-to-value ratio and full compliance with regulatory requirements.

ECP Emerging Growth Limited has reported steady financial health for its convertible notes, maintaining a 28.03% loan-to-value ratio and full compliance with regulatory requirements for the quarter ending December 2025.

Mesoblast Limited reports a 60% jump in Ryoncil sales for the December quarter, underpinned by a new $125 million financing facility that strengthens its balance sheet and strategic flexibility.

Coronado Global Resources has finalized its financial support agreement with Stanwell Corporation, cementing previously disclosed terms and providing clarity on its capital position.

Lendlease has reported a return to profit in FY25 alongside significant capital recycling and board renewal, setting the stage for a strategic transition year in FY26 with a planned $500 million share buyback.

EBR Systems has achieved a major commercial milestone with Medicare reimbursement approvals for its wireless cardiac pacing WiSE CRT System, driving a 201% revenue increase in Q3 2025. The company is advancing its Limited Market Release as it scales adoption in the US.

Block, Inc. reported a modest 2% revenue increase in Q3 2025 driven by growth in its Cash App and Square segments, alongside a $461.5 million net income. The company issued $2.2 billion in senior notes and repurchased $1.5 billion in stock, while navigating ongoing regulatory scrutiny and legal challenges.